Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts

Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis: A Systematic Review and Meta-Analysis

(2018) Roni Shouval et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma

(2018) Keith M. Sullivan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis

(2017) Nicole S. Goh et al.   Arthritis & Rheumatology

JMFit: ASASMacro for Joint Models of Longitudinal and Survival Data

(2016) Danjie Zhang et al.   Journal of Statistical Software

Derivation and External Validation of a Prediction Rule for Five-Year Mortality in Patients With Early Diffuse Cutaneous Systemic Sclerosis

(2016) Robyn T. Domsic et al.   Arthritis & Rheumatology

Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial

(2016) Donald P Tashkin et al.   Lancet Respiratory Medicine

Low-dose pulse cyclophosphamide in interstitial lung disease associated with systemic sclerosis (SSc-ILD): Efficacy of maintenance immunosuppression in responders and non-responders

(2015) Michele Iudici et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis

(2014) Jacob M. van Laar et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Interstitial lung disease in systemic sclerosis

(2014) Athol U. Wells   PRESSE MEDICALE

Prediction of Pulmonary Complications and Long-Term Survival in Systemic Sclerosis

(2014) Svetlana I. Nihtyanova et al.   Arthritis & Rheumatology

Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies

(2011) M. Elhai et al.   RHEUMATOLOGY

Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

(2010) A. J. Tyndall et al.   ANNALS OF THE RHEUMATIC DISEASES

A brief guide to model selection, multimodel inference and model averaging in behavioural ecology using Akaike’s information criterion

(2010) Matthew R. E. Symonds et al.   BEHAVIORAL ECOLOGY AND SOCIOBIOLOGY

Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort

(2010) Shervin Assassi et al.   ARTHRITIS RESEARCH & THERAPY

Treatment of Scleroderma-Interstitial Lung Disease With Cyclophosphamide Is Associated With Less Progressive Fibrosis on Serial Thoracic High-Resolution CT Scan Than Placebo

(2009) Jonathan Goldin et al.   CHEST

Classification of Parenchymal Abnormality in Scleroderma Lung Using a Novel Approach to Denoise Images Collected via a Multicenter Study

(2008) Hyun J. Kim et al.   ACADEMIC RADIOLOGY